FDA Inspection 1005211 — Philips North America

Philips North America — FEI 3006648320

The FDA completed an inspection of Philips North America on March 3, 2017 in Cambridge, MA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 2 citations were issued during this inspection. Product area: Devices.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
March 3, 2017
Fiscal Year
2017
Product Type
Devices
Project Area
Compliance: Devices
Location
Cambridge, MA (United States)

Citations

IDCFRDescription
1471221 CFR 820.184DHR - not or inadequately maintained
316021 CFR 820.184Lack of or inadequate DHR procedures